Finance

Brands are getting more interested in reaching the platform’s 43 million users, which could open the floodgates for more growth.

Magnite and The Trade Desk get even more time to expand their high-growth CTV businesses.

Disney nixes its first cruise in more than a year, and the rest of the industry is off to a slow recovery this season.

This retail winner has more room to run.

The IT services giant remains the best house in a boring neighborhood.

Dogecoin made more headlines with Tesla CEO Elon Musk continuing to tweet about the meme-inspired currency.

The clinical-stage biotech announced the pricing of a secondary stock offering.

The company gives investors exposure to three different markets.

Shares of the iconic owner of the Playboy brand went higher on an event that would normally push a stock lower. Here’s what you need to know.

NovoCure’s unique treatment for cancerous tumors is both a medical breakthrough and an investment opportunity.

GP earnings call for the period ending March 31, 2021.

Some stocks you can buy and forget. With Zomedica and ContextLogic, you’ll want to keep a much closer eye on matters.

The company has found a partner to manufacture its COVID-19 vaccine — but will it be all for naught?

A top analyst calls Netflix out for not cashing in on the connected-TV advertising craze.

Investors looking to add a top chip stock to their portfolios will find a gem among these three companies.

Companies big and small will face the necessary evils of regulations.

Too much good news in a short time has NVIDIA’s stock price climbing to new highs.

Two well-run retailers recently announced 30%-plus increases to their dividend payouts.

Despite the vaccine windfall and an impressive pipeline, shareholders might need the company’s encore sooner than expected.

Chatting with Malcolm Ethridge about financial success and meme stocks.